Hyperlipoproteinemia Type II
Showing 9976 - 10000 of >10,000
Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell
Active, not recruiting
- Stage I Lung Non-Small Cell Cancer AJCC v7
- +6 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 24, 2022
Spectrum of Bacterial Infections in Rheumatology
Completed
- Articular Disease
- Groups/Cohortes
-
Pontoise, FranceDepartment of Rheumatology, Hospital René Dubos, Pontoise
Jan 25, 2022
Premature Birth, Obstetric Labor, Premature Trial in New York, San Antonio (Family Nurture Intervention, Standard Care)
Active, not recruiting
- Premature Birth
- Obstetric Labor, Premature
- Family Nurture Intervention
- Standard Care
-
New York, New York
- +1 more
Sep 16, 2022
Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
-
St. Gallen, SwitzerlandMuskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
May 19, 2023
Glioblastoma, Brain Tumors Trial in Gainesville, Saint Louis (device, procedure, genetic)
Terminated
- Glioblastoma
- Brain Neoplasms
- NovoTTF-100A
- +2 more
-
Gainesville, Florida
- +1 more
Nov 19, 2021
COVID-19 Pneumonia, Virus Diseases, COVID-19 Trial in Istanbul (Signal Therapy provided by Dr.Biolyse device, Liquid Support
Recruiting
- COVID-19 Pneumonia
- +2 more
- Signal Therapy provided by Dr.Biolyse device
- Liquid Support Treatment
-
Istanbul, TurkeyBezmialem Vakif University Dragos Hospital
Oct 31, 2023
Atrial Fibrillation, Type 2 Diabetes Trial in Ottawa (High-intensity interval training + standard care)
Recruiting
- Atrial Fibrillation
- Type 2 Diabetes
- High-intensity interval training + standard care
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Dec 10, 2021
Sleep, Gut Microbiome, Cardiometabolic Risk Trial in Singapore (Dietary protein)
Not yet recruiting
- Sleep
- +2 more
- Dietary protein
-
Singapore, SingaporeNational University of Singapore
Sep 27, 2022
Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)
Not yet recruiting
- Classical Hodgkin Lymphoma
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Aug 5, 2022
Nasalance Scores for Normal-speaking French Children
Recruiting
- Resonance Disorder
- Nasometry
-
Paris, FranceHôpital Necker-Enfants Malades
Oct 24, 2022
Clostridium Difficile Infection Trial (FMT Capsule DE, Placebo oral capsule)
Withdrawn
- Clostridium Difficile Infection
- FMT Capsule DE
- Placebo oral capsule
- (no location specified)
Feb 19, 2021
Diabetes, Type 2, Weight Change, Body Trial in Peshawar, Karachi (Semaglutide Pen Injector)
Recruiting
- Diabetes Mellitus, Type 2
- Weight Change, Body
- Semaglutide Pen Injector
-
Peshawar, KPK, Pakistan
- +1 more
Aug 3, 2022
Chronic Non-malignant Pain, Chronic Pain, Pain, Back Trial in United States (Medtronic SynchroMed™ II infusion system,
Completed
- Chronic Non-malignant Pain
- +3 more
- Medtronic SynchroMed™ II infusion system
- Preservative-free morphine sulfate (PFMS)
-
Anchorage, Alaska
- +15 more
Dec 9, 2021
Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin Lymphoma
- UF-KURE19 CAR-T cells
- +2 more
-
Cleveland, Ohio
- +1 more
Nov 21, 2022
Lidocaine Trial in Kaohsiung (Lidocaine, Normal saline)
Not yet recruiting
- Lidocaine
- Lidocaine
- Normal saline
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Jan 29, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, IMRT 60-66Gy)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Pembrolizumab
- IMRT 60-66Gy
-
Cleveland, Ohio
- +1 more
Jun 29, 2022
Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,
Not yet recruiting
- Advanced Uveal Melanoma
- +2 more
- BRD4 Inhibitor PLX2853
- +4 more
- (no location specified)
Jan 9, 2023
Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Tislelizumab
- +3 more
- (no location specified)
May 7, 2023
Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- dapagliflozin (Forxiga)
- (no location specified)
Mar 13, 2023
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Asbestos Exposure Trial in Hamilton (Artichoke WPC)
Completed
- Asbestos Exposure
- Artichoke WPC
-
Hamilton, Ontario, CanadaSt. Joseph's Hospital, Firestone Institute
Jul 12, 2021
Diabetes, Type 1 Trial in Prague (Insulin Pump t:slim X2 with Control-IQ technology)
Recruiting
- Diabetes Mellitus, Type 1
- Insulin Pump t:slim X2 with Control-IQ technology
-
Prague, Czechia3rd Department of Internal Medicine, 1st Faculty of Medicine, Ch
Dec 14, 2021
Language Disorders in Children Trial in Cairo (Methylprednisolone and or prednisolone)
Completed
- Language Disorders in Children
- Methylprednisolone and or prednisolone
-
Cairo, EgyptOmnia Alaa Mahsoub
Aug 2, 2022
Diaphragm Dysfunction Trial in Paris (Transdiaphragmatic pressure measurement, EMG)
Not yet recruiting
- Diaphragm Dysfunction
- Transdiaphragmatic pressure measurement
- EMG
-
Paris, FranceDépartement R3S - Hôpital Pitié-Salpêtrière
Mar 28, 2022
Pre Diabetes, Diabetes, Type 2 Trial (Produce Prescription Group)
Not yet recruiting
- Pre Diabetes
- Diabetes Mellitus, Type 2
- Produce Prescription Group
- (no location specified)
Jun 30, 2023